Study S000241

A Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Study to Assess the Efficacy and Safety of XW003 Injections in Obese Participants With Obstructive Sleep Apnea Receiving Positive Airway Pressure Therapy

ClinicalTrials.gov record

Registration

Registration: NCT07434050
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE3
Masking: DOUBLE
Status: RECRUITING
Enrollment: 140
Start: 2026-03-02
Primary completion: 2028-06-19
Lead sponsor: Hangzhou Sciwind Biosciences Co., Ltd.
Conditions: OSA - Obstructive Sleep Apnea; Obesity
Interventions: DRUG:XW003 injection; DRUG:placebo with matching volume
Results posted: FALSE

Registered primary outcomes

Change from baseline in Apnea-Hypopnea Index (AHI) [at week 48]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.